Bio-Rad Laboratories Led $105 Million Series C Funding Round for Geneoscopy

MT Newswires Live

01-08

Bio-Rad Laboratories (BIO) led the Series C financing round for Geneoscopy, which raised $105 million, the latter said Wednesday.

Geneoscopy said it plans to use the funding to commercialize its at-home stool-based colorectal cancer screening test, ColoSense, and continue the development of diagnostic products for inflammatory bowel disease.

The gastrointestinal diagnostics development company said investor Labcorp Holdings (LH) will help distribute ColoSense, integrating it into healthcare providers' screening programs.

Price: 337.37, Change: -6.63, Percent Change: -1.93

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2501277695"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2501277695\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2501277695?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-01-08 23:10","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2501277695","market":"us","top_or_hot":-1,"title":"Bio-Rad Laboratories Led $105 Million Series C Funding Round for Geneoscopy","media":"MT Newswires Live","content":"<html><body><p> Bio-Rad Laboratories (BIO) led the Series C financing round for Geneoscopy, which raised $105 million, the latter said Wednesday.</p><p>Geneoscopy said it plans to use the funding to commercialize its at-home stool-based colorectal cancer screening test, ColoSense, and continue the development of diagnostic products for inflammatory bowel disease.</p><p>The gastrointestinal diagnostics development company said investor Labcorp Holdings (LH) will help distribute ColoSense, integrating it into healthcare providers' screening programs.</p><p>Price: 337.37, Change: -6.63, Percent Change: -1.93</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n<meta content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\" name=\"viewport\"/>\n<meta content=\"telephone=no,email=no,address=no\" name=\"format-detection\"/>\n<title>Bio-Rad Laboratories Led $105 Million Series C Funding Round for Geneoscopy</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBio-Rad Laboratories Led $105 Million Series C Funding Round for Geneoscopy\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-01-08 23:10</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p> Bio-Rad Laboratories (BIO) led the Series C financing round for Geneoscopy, which raised $105 million, the latter said Wednesday.</p><p>Geneoscopy said it plans to use the funding to commercialize its at-home stool-based colorectal cancer screening test, ColoSense, and continue the development of diagnostic products for inflammatory bowel disease.</p><p>The gastrointestinal diagnostics development company said investor Labcorp Holdings (LH) will help distribute ColoSense, integrating it into healthcare providers' screening programs.</p><p>Price: 337.37, Change: -6.63, Percent Change: -1.93</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK7111","symbol_name":"个人用品","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2501277695","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2501277695","pubTimestamp":1736349040,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Bio-Rad Laboratories (BIO) led the Series C financing round for Geneoscopy, which raised $105 million, the latter said Wednesday.Geneoscopy said it plans to use the funding to commercialize its at-hom","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK7111":"个人用品","BK4588":"碎股","BIO.B":"Bio-Rad Laboratories Inc Cl B","LU1169589451.USD":"ALLSPRING (LUX)  U.S. SELECT EQUITY \"A\" (USD) ACC","BK4196":"保健护理服务","LU0006061336.USD":"Blackrock US Small and MidCap Opportunities A2 USD","BIO.AU":"BIOME AUSTRALIA LTD","LH":"徕博科","BK4121":"生命科学工具和服务","BK4585":"ETF&股票定投概念","LU1169590202.USD":"ALLSPRING (LUX)  U.S. SELECT EQUITY \"I\" (USD) ACC","BK4550":"红杉资本持仓","BIO":"Bio Rad实验室"},"translate_title":"Bio-Rad Laboratories领投基因镜1.05亿美元C轮融资","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BIO.AU":1,"BIO.B":1,"BIO":0.9,"LH":0.9},"content_text":"Bio-Rad Laboratories (BIO) led the Series C financing round for Geneoscopy, which raised $105 million, the latter said Wednesday.Geneoscopy said it plans to use the funding to commercialize its at-home stool-based colorectal cancer screening test, ColoSense, and continue the development of diagnostic products for inflammatory bowel disease.The gastrointestinal diagnostics development company said investor Labcorp Holdings (LH) will help distribute ColoSense, integrating it into healthcare providers' screening programs.Price: 337.37, Change: -6.63, Percent Change: -1.93","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":1}}}